Hot Stocks Of The day (RIMM, NEON, PWRD, PBY, ISR)

Research In Motion Limited (USA) (NASDAQ:RIMM) shares fell 9.44% to $10.17 in the pre-market hour after the company said it has hired bankers to provide strategic review and are also looking for partnerships as the company warned that it is likely report a loss in the first-quarter results. Moreover, the company would also cut a significant number of jobs, though it did not say how many. However sources revealed that it plans to cut its workforce closer to 10,000 by early next year from 16,500 currently.

Neonode, Inc (NASDAQ:NEON) shares soared 29.08% to $6.17 in the pre-market hour after Solimar Energy Limited announced that it has come to an agreement with Neon Energy Limited involving a revised project ownership structure which better matches each company's corporate objectives and provides Solimar with funding through the two new wells that are currently being drilled or in completion.

Perfect World Co., Ltd. (ADR) (NASDAQ:PWRD) stock plunged 11.30% to $10.20 in the pre-market hour after the company reported first quarter net income of 209.8 million renminbis or 4.38 renminbis per American Depositary Share, or ADS, as compared to 263.7 million renminbis or 4.99 renminbis per ADS. Non-GAAP net income was 231.6 renminbis or 4.83 renminbis per Ads, as against 289.5 renminbis or 4.99 renminbis per ADS. Total revenues were 718.5 million renminibis, as compared to 718.5 million renminbis in the year-ago quarter.

The Pep Boys - Manny, Moe & Jack (NYSE:PBY) stock plunged 22.45% to $8.60 in the pre-market hour after the company announced that it has agreed to terminate the proposed merger between Pep Boys and The Gores Group. As settlement for any and all potential claims that Pep Boys could assert under the terms of the merger agreement, The Gores Group has agreed to pay Pep Boys a fee of $50 million and to reimburse Pep Boys for certain merger-related expenses. The special meeting of Pep Boys’ shareholders, which was scheduled to be held on May 30, 2012, has been cancelled.

IsoRay, Inc. (NYSEAMEX:ISR) shares gained 2.56% to $1.20 in the pre-market hour after the company yesterday announced that Discovery Channel has featured the Company's Cesium-131 brachytherapy (internal radiation therapy) treatment for localized prostate cancer. Discovery Channel Chief Medical Expert John Whyte, MD, MPH, spoke with UPMC urologist Dr. Ronald Benoit about the advantages of using Cesium-131 over traditional isotopes. UPMC's study found that its patients benefited from the minimally invasive treatment that resulted in reduced urinary problems.